BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2060063)

  • 1. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins.
    Venkitaraman AR; Baatz JE; Whitsett JA; Hall SB; Notter RH
    Chem Phys Lipids; 1991; 57(1):49-57. PubMed ID: 2060063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1990 Oct; 1046(3):233-41. PubMed ID: 2223863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activity and lack of synergy of lung surfactant proteins SP-B and SP-C in interactions with phospholipids.
    Wang Z; Gurel O; Baatz JE; Notter RH
    J Lipid Res; 1996 Aug; 37(8):1749-60. PubMed ID: 8864959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A.
    Venkitaraman AR; Hall SB; Whitsett JA; Notter RH
    Chem Phys Lipids; 1990 Dec; 56(2-3):185-94. PubMed ID: 2095991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of surfactant protein A on regional organization of phospholipid monolayers containing surfactant protein B or C.
    Taneva SG; Keough KM
    Biophys J; 2000 Oct; 79(4):2010-23. PubMed ID: 11023905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorption of pulmonary surfactant protein SP-A to monolayers of phospholipids containing hydrophobic surfactant protein SP-B or SP-C: potential differential role for tertiary interaction of lipids, hydrophobic proteins, and SP-A.
    Taneva SG; Keough KM
    Biochemistry; 2000 May; 39(20):6083-93. PubMed ID: 10821681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pulmonary surfactant protein B (SP-B) and calcium on phospholipid adsorption and squeeze-out of phosphatidylglycerol from binary phospholipid monolayers containing dipalmitoylphosphatidylcholine.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1992 Jun; 1126(1):26-34. PubMed ID: 1606172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylation of pulmonary surfactant protein-C is required for its optimal surface active interactions with phospholipids.
    Wang Z; Gurel O; Baatz JE; Notter RH
    J Biol Chem; 1996 Aug; 271(32):19104-9. PubMed ID: 8702584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: III. Proteins SP-B plus SP-C with phospholipids in spread monolayers.
    Taneva S; Keough KM
    Biophys J; 1994 Apr; 66(4):1158-66. PubMed ID: 8038387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
    Holm BA; Wang Z; Egan EA; Notter RH
    Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: I. Monolayers of pulmonary surfactant protein SP-B and phospholipids.
    Taneva S; Keough KM
    Biophys J; 1994 Apr; 66(4):1137-48. PubMed ID: 8038385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitoylation of a pulmonary surfactant protein C analogue affects the surface associated lipid reservoir and film stability.
    Gustafsson M; Palmblad M; Curstedt T; Johansson J; Schürch S
    Biochim Biophys Acta; 2000 Jun; 1466(1-2):169-78. PubMed ID: 10825440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic homopolymeric peptides enhance the biophysical activity of synthetic lung phospholipids.
    Venkitaraman AR; Hall SB; Notter RH
    Chem Phys Lipids; 1990 Mar; 53(2-3):157-64. PubMed ID: 2337975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1988 Aug; 961(3):337-50. PubMed ID: 3401500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surfactant proteins in DPPC enrichment of surface films.
    Veldhuizen EJ; Batenburg JJ; van Golde LM; Haagsman HP
    Biophys J; 2000 Dec; 79(6):3164-71. PubMed ID: 11106621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
    Cockshutt AM; Weitz J; Possmayer F
    Biochemistry; 1990 Sep; 29(36):8424-9. PubMed ID: 2252903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
    Palmblad M; Johansson J; Robertson B; Curstedt T
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP-B refining of pulmonary surfactant phospholipid films.
    Nag K; Munro JG; Inchley K; Schürch S; Petersen NO; Possmayer F
    Am J Physiol; 1999 Dec; 277(6):L1179-89. PubMed ID: 10600889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
    Seeger W; Thede C; Günther A; Grube C
    Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.